We recognize the many challenges employers are facing as a result of COVID-19. That’s why we developed the COVID-19 Deductible Savings Endorsement—a no-cost provision designed to help reduce the impact of COVID-19 claims on self-funded plans.
How the Deductible Savings Endorsement can help:
The details are simple. If a claimant’s primary diagnosis is COVID-19 and the claim includes inpatient hospitalization related to the COVID-19 diagnosis, Symetra will reduce the Specific deductible for that claimant by $3,000.
The COVID-19 Deductible Savings Endorsement is offered on all Symetra Stop Loss policies with effective dates from January 1 through March 31, 2021, in approved states. To learn more, contact your Symetra Stop Loss representative.
